LGE Seen on MRI Top Risk Factor for HCM

To date, risk assessment in patients with hypertrophic cardiomyopathy (HCM) has largely focused on whether there is a need for an implantable defibrillator by evaluating an individual patient’s short term risk of sudden death, but has not looked at the long term risks of heart failure and other adverse outcomes over time.

A recent retrospective study by European HCM specialists asked the question of whether the addition of advanced imaging could assist in pinpointing patients at high risk of heart failure and/or other serious HCM complications over time. 

Continue reading “LGE Seen on MRI Top Risk Factor for HCM”

BNP and Troponin Levels in HCM: USEFULNESS OF BLOOD TESTS 

gringer-Blood-tube-vaccuum-style

 Image by Ocal - http://www.clker.com/clipart-13766.html

Doctors from Cedars-Sinai Hospital Center for HCM and Aortopathies say that certain blood test results  – specifically BNP and Troponin levels – are useful in evaluating HCM patients, particularly with respect to risk stratification and guidance of medical therapy.